← Open Payments lookup

KAITLYN DIAZ: Open Payments

NPI 1154184943 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,542 in 204 payments from 26 companies in 2025. Trend: 2023 $166 · 2024 $3,504 · 2025 $5,542

Food & beverage: $5,443Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP24$1,029
Regeneron Healthcare Solutions, Inc.12$566
GENZYME CORPORATION12$478
Galderma Laboratories, L.P.13$451
CSL Behring24$433
Genentech USA, Inc.13$365
ARS Pharmaceuticals Operations, Inc.11$342
Novartis Pharmaceuticals Corporation12$236
GlaxoSmithKline, LLC.17$206
Takeda Pharmaceuticals U.S.A., Inc.10$193

Products named: DUPIXENT, NEMLUVIO, TEZSPIRE, Xolair, NEFFY, FASENRA, Andembry, AIRSUPRA.

Industry payments across TX — which companies pay providers there.